These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 2411538)
21. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878 [TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Talmage DA; Freund R; Young AT; Dahl J; Dawe CJ; Benjamin TL Cell; 1989 Oct; 59(1):55-65. PubMed ID: 2551507 [TBL] [Abstract][Full Text] [Related]
23. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Courtneidge SA; Smith AE Nature; 1983 Jun 2-8; 303(5916):435-9. PubMed ID: 6304524 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity. Way BA; Mooney RA Mol Cell Biochem; 1994 Oct; 139(2):167-75. PubMed ID: 7532275 [TBL] [Abstract][Full Text] [Related]
25. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725 [TBL] [Abstract][Full Text] [Related]
26. Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells. Bolen JB; DeSeau V; O'Shaughnessy J; Amini S J Virol; 1987 Oct; 61(10):3299-305. PubMed ID: 2442413 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells. Yang YW; Chang YH Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159 [TBL] [Abstract][Full Text] [Related]
28. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src. Bolen JB; Amini S; DeSeau V; Reddy S; Shalloway D J Virol; 1987 Apr; 61(4):1079-85. PubMed ID: 2434664 [TBL] [Abstract][Full Text] [Related]
29. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src. Gorga FR; Riney CE; Benjamin TL J Virol; 1990 Jan; 64(1):105-12. PubMed ID: 2152807 [TBL] [Abstract][Full Text] [Related]
30. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
31. Effects of doxorubicin on pp60c-src kinase activity in polyoma virus MT antigen transformed cells. Yang YW; Chang YH Anticancer Res; 1994; 14(6B):2529-35. PubMed ID: 7532928 [TBL] [Abstract][Full Text] [Related]
32. Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src. Coussens PM; Cooper JA; Hunter T; Shalloway D Mol Cell Biol; 1985 Oct; 5(10):2753-63. PubMed ID: 2426575 [TBL] [Abstract][Full Text] [Related]
33. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Zheng XM; Wang Y; Pallen CJ Nature; 1992 Sep; 359(6393):336-9. PubMed ID: 1383828 [TBL] [Abstract][Full Text] [Related]
34. Phosphoinositide kinase activity and transformation. Whitman M; Kaplan D; Cantley L; Roberts TM; Schaffhausen B Fed Proc; 1986 Oct; 45(11):2647-52. PubMed ID: 3019785 [TBL] [Abstract][Full Text] [Related]
35. Protein kinase C stimulation increases the transforming ability of the polyoma virus middle T antigen. Raptis L; Whitfield JF Biochem Biophys Res Commun; 1986 Nov; 140(3):1106-12. PubMed ID: 2430571 [TBL] [Abstract][Full Text] [Related]
36. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes. Roche S; Dhand R; Waterfield MD; Courtneidge SA Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847 [TBL] [Abstract][Full Text] [Related]
37. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src. Roussel RR; Brodeur SR; Shalloway D; Laudano AP Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546 [TBL] [Abstract][Full Text] [Related]
38. c-Src and mitosis. Shalloway D; Bagrodia S; Chackalaparampil I; Shenoy S; Lin PH; Taylor SJ Ciba Found Symp; 1992; 170():248-65; discussion 265-75. PubMed ID: 1282857 [TBL] [Abstract][Full Text] [Related]
39. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Cobb BS; Parsons JT Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368 [TBL] [Abstract][Full Text] [Related]
40. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function. Talmage DA; Riney C; Benjamin TL Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]